Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Biomed Inform. 2010 May 1;43(3):376–384. doi: 10.1016/j.jbi.2010.04.006

Figure 1. Illustration of raw data and their relationship in this study.

Figure 1

The frequencies of adverse events (AEs) associated with kinase inhibitors were curated from three sources (Thompson Physician Desk Reference, PharmGKB and PubMed). The dissociation constants (Kd) of kinases were summarized from physico-chemical assays[8]. The computational method in this study considers all of these data to predict the association between AEs and targets of kinase inhibitors.